Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.
Bristol Myers Squibb Co. is challenging a federal health agency for denying its plan to implement a rebate model for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback